BMJ partners with CoMo Consortium to help countries contain spread of COVID-19

BMJ will disseminate findings to help inform public health responses in over 40 countries 

Leading healthcare knowledge provider BMJ has partnered with the COVID-19 International Modelling Consortium (CoMo Consortium) to promote their policy recommendations and findings to help countries contain the spread of COVID-19.

The COVID-19 International Modelling Consortium (CoMo Consortium) was created by researchers at the University of Oxford and Cornell University. It brings together infectious disease and economic modellers with public health experts from over 40 countries across Africa, Asia and America. 

The consortium assists policymakers in making evidence-based decisions to contain the spread of COVID-19, based on evidence from economic and epidemiological models adapted to each country’s context.

During this one-year agreement, BMJ will provide technical, communications, and project management services to help disseminate policy recommendations and findings to health professionals, governments and related organisations across the world. 

“It is crucial to have a direct link between the experts involved in developing the models, local in-country modellers, public health experts and policymakers in each country if we are to help them to deal with their specific COVID-19 situation,” says Mitali Wroczynski, Director of Global Health at BMJ. “We are delighted to be involved in disseminating this important work, being part of efforts to tackle the pandemic and helping to create a healthier world.”

Lisa White, Professor of Modelling and Epidemiology at the University of Oxford and Director of the CoMo Consortium, adds: “Our approach in the CoMo Consortium represents a new more equitable way to conduct pandemic modelling. Here, experts within the country teams take the leading role in modelling the pandemic working closely with national policymakers. Researchers at Oxford provide technical and consultative support as needed. Modelling work is carried out within the health and policy context of each country leading to rapid uptake of results via continuous communication with the decision makers.”

[Ends]

15/12/2020

Notes to Editors:

For further information contact BMJ media relations team:

mediarelations@bmj.com

About BMJ

BMJ is a healthcare knowledge provider with a vision for a healthier world. As a values-driven company serving communities everywhere, BMJ helps improve global health outcomes by providing evidence-based knowledge and education.  

We collaborate with global partners in low- and middle-income countries to put reliable information and tools into the hands of health professionals. Together we are strengthening health systems, building capacity and changing the course of human health – one patient at a time. 

For more information, go to https://beta-www.bmj.com/company/global-health-initiatives/